Asset Allocation

As of November 30, 2025.
Type % Net
Cash 61.89%
Stock 26.97%
Bond 11.87%
Convertible 0.00%
Preferred 0.00%
Other -0.72%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 100.1%    % Emerging Markets: 1.01%    % Unidentified Markets: -1.14%

Americas 97.82%
96.83%
Canada 72.57%
United States 24.26%
0.99%
Brazil 0.00%
Mexico 0.00%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.97%
United Kingdom 1.87%
0.09%
0.00%
0.00%
Saudi Arabia 0.00%
South Africa 0.00%
United Arab Emirates 0.00%
Greater Asia 1.35%
Japan 0.00%
0.00%
Australia 0.00%
1.33%
Hong Kong 1.33%
South Korea 0.00%
Taiwan 0.00%
0.02%
China 0.02%
India 0.00%
Unidentified Region -1.14%

Bond Credit Quality Exposure

AAA 0.00%
AA 0.65%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 99.35%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
11.57%
Materials
0.44%
Consumer Discretionary
5.98%
Financials
5.14%
Real Estate
0.00%
Sensitive
10.01%
Communication Services
3.34%
Energy
3.42%
Industrials
0.71%
Information Technology
2.55%
Defensive
5.61%
Consumer Staples
3.99%
Health Care
0.66%
Utilities
0.96%
Not Classified
72.81%
Non Classified Equity
0.00%
Not Classified - Non Equity
72.81%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 15.06%
Corporate 65.62%
Securitized 13.33%
Municipal 0.00%
Other 5.99%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
99.29%
Less than 1 Year
99.29%
Intermediate
0.00%
1 to 3 Years
0.00%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.71%
10 to 20 Years
0.01%
20 to 30 Years
0.70%
Over 30 Years
0.00%
Other
0.00%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial